Liberum Capital restated their buy rating on shares of Udg Healthcare PLC (LON:UDG) in a report issued on Thursday. They currently have a GBX 930 ($12.27) target price on the stock.

Several other brokerages have also weighed in on UDG. Peel Hunt increased their price objective on shares of Udg Healthcare PLC from GBX 730 ($9.63) to GBX 830 ($10.95) and gave the company an add rating in a report on Tuesday, May 23rd. Berenberg Bank lowered shares of Udg Healthcare PLC to a hold rating and set a GBX 745 ($9.83) price objective on the stock. in a report on Monday, May 8th. Jefferies Group LLC lowered shares of Udg Healthcare PLC to a hold rating and increased their price objective for the company from GBX 760 ($10.03) to GBX 785 ($10.35) in a report on Wednesday, May 24th. N+1 Singer restated a hold rating on shares of Udg Healthcare PLC in a report on Thursday. Finally, Numis Securities Ltd restated a hold rating and issued a GBX 730 ($9.63) price objective on shares of Udg Healthcare PLC in a report on Tuesday, May 23rd. Six investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of Hold and an average target price of GBX 799.43 ($10.55).

Udg Healthcare PLC (UDG) opened at 831.50 on Thursday. The firm’s market cap is GBX 2.06 billion. The firm has a 50-day moving average of GBX 847.66 and a 200 day moving average of GBX 751.72. Udg Healthcare PLC has a 52-week low of GBX 567.00 and a 52-week high of GBX 886.50.

TRADEMARK VIOLATION NOTICE: This article was posted by Daily Political and is the property of of Daily Political. If you are reading this article on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The original version of this article can be viewed at https://www.dailypolitical.com/2017/08/07/udg-healthcare-plc-lonudg-earns-buy-rating-from-liberum-capital.html.

In other Udg Healthcare PLC news, insider Chris Corbin sold 100,000 shares of the company’s stock in a transaction that occurred on Monday, June 5th. The shares were sold at an average price of GBX 813 ($10.72), for a total value of £813,000 ($1,072,417.89). Also, insider Jez Moulding bought 18,000 shares of the stock in a transaction on Wednesday, May 31st. The stock was purchased at an average cost of GBX 808 ($10.66) per share, with a total value of £145,440 ($191,848.04).

Udg Healthcare PLC Company Profile

UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies.

Analyst Recommendations for Udg Healthcare PLC (LON:UDG)

Receive News & Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related companies with MarketBeat.com's FREE daily email newsletter.